Treatment of biofilm communities: An update on new tools from the nanosized world

Federico Bertoglio, Nora Bloise, Martina Oriano, Paola Petrini, Simone Sprio, Marcello Imbriani, Anna Tampieri, Livia Visai

Research output: Contribution to journalReview article

Abstract

Traditionally regarded as single cell organisms, bacteria naturally and preferentially build multicellular communities that enable them to react efficiently to external stimuli in a coordinated fashion and with extremely effective outcomes. These communities are bacterial biofilms, where single cells or microcolonies are embedded in self-built Extracellular Polymeric Substance (EPS), composed of different macromolecules, e.g., polysaccharides, proteins, lipids, and extracellular DNA (eDNA). Despite being the most common form in nature and having many biotechnologically useful applications, biofilm is often regarded as a life-threatening form of bacterial infection. Since this form of bacterial life is intrinsically more resistant to antibiotic treatment and antimicrobial resistance is reaching alarming levels, we will focus our attention on how nanotechnology made new tools available to the medical community for the prevention and treatment of these infections. After a brief excursus on biofilm formation and its main characteristics, different types of nanomaterials developed to prevent or counteract these multicellular forms of bacterial infection will be described. A comparison of different classifications adopted for nanodrugs and a final discussion of challenges and future perspectives are also presented.

Original languageEnglish
Article number845
JournalApplied Sciences (Switzerland)
Volume8
Issue number6
DOIs
Publication statusPublished - May 23 2018

Fingerprint

biofilms
Biofilms
infectious diseases
antibiotics
polysaccharides
Antibiotics
Polysaccharides
nanotechnology
cells
Macromolecules
Nanotechnology
organisms
macromolecules
Nanostructured materials
stimuli
Lipids
bacteria
lipids
Bacteria
DNA

Keywords

  • Antibacterial nanomaterials
  • Biofilm
  • Nanomedicine
  • Nanoparticles

ASJC Scopus subject areas

  • Materials Science(all)
  • Instrumentation
  • Engineering(all)
  • Process Chemistry and Technology
  • Computer Science Applications
  • Fluid Flow and Transfer Processes

Cite this

Treatment of biofilm communities : An update on new tools from the nanosized world. / Bertoglio, Federico; Bloise, Nora; Oriano, Martina; Petrini, Paola; Sprio, Simone; Imbriani, Marcello; Tampieri, Anna; Visai, Livia.

In: Applied Sciences (Switzerland), Vol. 8, No. 6, 845, 23.05.2018.

Research output: Contribution to journalReview article

Bertoglio, Federico ; Bloise, Nora ; Oriano, Martina ; Petrini, Paola ; Sprio, Simone ; Imbriani, Marcello ; Tampieri, Anna ; Visai, Livia. / Treatment of biofilm communities : An update on new tools from the nanosized world. In: Applied Sciences (Switzerland). 2018 ; Vol. 8, No. 6.
@article{fd3b903cbcdd48418e0c1f79897b69af,
title = "Treatment of biofilm communities: An update on new tools from the nanosized world",
abstract = "Traditionally regarded as single cell organisms, bacteria naturally and preferentially build multicellular communities that enable them to react efficiently to external stimuli in a coordinated fashion and with extremely effective outcomes. These communities are bacterial biofilms, where single cells or microcolonies are embedded in self-built Extracellular Polymeric Substance (EPS), composed of different macromolecules, e.g., polysaccharides, proteins, lipids, and extracellular DNA (eDNA). Despite being the most common form in nature and having many biotechnologically useful applications, biofilm is often regarded as a life-threatening form of bacterial infection. Since this form of bacterial life is intrinsically more resistant to antibiotic treatment and antimicrobial resistance is reaching alarming levels, we will focus our attention on how nanotechnology made new tools available to the medical community for the prevention and treatment of these infections. After a brief excursus on biofilm formation and its main characteristics, different types of nanomaterials developed to prevent or counteract these multicellular forms of bacterial infection will be described. A comparison of different classifications adopted for nanodrugs and a final discussion of challenges and future perspectives are also presented.",
keywords = "Antibacterial nanomaterials, Biofilm, Nanomedicine, Nanoparticles",
author = "Federico Bertoglio and Nora Bloise and Martina Oriano and Paola Petrini and Simone Sprio and Marcello Imbriani and Anna Tampieri and Livia Visai",
year = "2018",
month = "5",
day = "23",
doi = "10.3390/app8060845",
language = "English",
volume = "8",
journal = "Applied Sciences (Switzerland)",
issn = "2076-3417",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

TY - JOUR

T1 - Treatment of biofilm communities

T2 - An update on new tools from the nanosized world

AU - Bertoglio, Federico

AU - Bloise, Nora

AU - Oriano, Martina

AU - Petrini, Paola

AU - Sprio, Simone

AU - Imbriani, Marcello

AU - Tampieri, Anna

AU - Visai, Livia

PY - 2018/5/23

Y1 - 2018/5/23

N2 - Traditionally regarded as single cell organisms, bacteria naturally and preferentially build multicellular communities that enable them to react efficiently to external stimuli in a coordinated fashion and with extremely effective outcomes. These communities are bacterial biofilms, where single cells or microcolonies are embedded in self-built Extracellular Polymeric Substance (EPS), composed of different macromolecules, e.g., polysaccharides, proteins, lipids, and extracellular DNA (eDNA). Despite being the most common form in nature and having many biotechnologically useful applications, biofilm is often regarded as a life-threatening form of bacterial infection. Since this form of bacterial life is intrinsically more resistant to antibiotic treatment and antimicrobial resistance is reaching alarming levels, we will focus our attention on how nanotechnology made new tools available to the medical community for the prevention and treatment of these infections. After a brief excursus on biofilm formation and its main characteristics, different types of nanomaterials developed to prevent or counteract these multicellular forms of bacterial infection will be described. A comparison of different classifications adopted for nanodrugs and a final discussion of challenges and future perspectives are also presented.

AB - Traditionally regarded as single cell organisms, bacteria naturally and preferentially build multicellular communities that enable them to react efficiently to external stimuli in a coordinated fashion and with extremely effective outcomes. These communities are bacterial biofilms, where single cells or microcolonies are embedded in self-built Extracellular Polymeric Substance (EPS), composed of different macromolecules, e.g., polysaccharides, proteins, lipids, and extracellular DNA (eDNA). Despite being the most common form in nature and having many biotechnologically useful applications, biofilm is often regarded as a life-threatening form of bacterial infection. Since this form of bacterial life is intrinsically more resistant to antibiotic treatment and antimicrobial resistance is reaching alarming levels, we will focus our attention on how nanotechnology made new tools available to the medical community for the prevention and treatment of these infections. After a brief excursus on biofilm formation and its main characteristics, different types of nanomaterials developed to prevent or counteract these multicellular forms of bacterial infection will be described. A comparison of different classifications adopted for nanodrugs and a final discussion of challenges and future perspectives are also presented.

KW - Antibacterial nanomaterials

KW - Biofilm

KW - Nanomedicine

KW - Nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85047480318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047480318&partnerID=8YFLogxK

U2 - 10.3390/app8060845

DO - 10.3390/app8060845

M3 - Review article

AN - SCOPUS:85047480318

VL - 8

JO - Applied Sciences (Switzerland)

JF - Applied Sciences (Switzerland)

SN - 2076-3417

IS - 6

M1 - 845

ER -